[阿兹特里奥纳姆/阿维巴克坦在抗生素治疗中的作用]
1Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Olomouc University Hospital, Czech Republic,
本综述涵盖了对产生卡巴酶的肠杆菌感染的治疗方法. 它强调阿兹特雷诺姆/阿维巴克坦作为对抗这些具有挑战性的多药耐药细菌的关键治疗选择.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 生产碳酶的肠道细菌 (CPE) 是一个日益增长的全球健康威胁.
- CPE感染与高发病率和死亡率有关.
- 对于CPE感染的治疗选择有限,需要新的治疗策略.
研究的目的:
- 审查CPE感染的当前治疗策略.
- 评估阿兹特雷诺姆/阿维巴克坦在治疗CPE感染中的疗效和作用.
- 提供对治疗CPE的挑战和未来方向的概述.
主要方法:
- 关于CPE治疗的已发表研究的文献综述.
- 临床数据和体外研究的分析.
- 专注于抗微生物药物,特别是阿兹特雷诺姆/阿维巴克坦.
主要成果:
- 阿兹特雷诺姆/阿维巴克坦对各种CPE表现出有希望的活性,包括那些产生不同类型的碳烯酶的CPE.
- 结合疗法方法通常是有效治疗的必要条件.
- 治疗结果受到感染部位,患者的并发症和局部耐药性模式等因素的影响.
结论:
- 阿兹特雷诺南/阿维巴克坦代表了对抗CPE感染的治疗武器库的宝贵补充.
- 有效的管理需要结合抗微生物管理,诊断和适当的治疗选择.
- 需要进一步的研究来优化治疗方案,并解决新出现的耐药性机制.
更多相关视频
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
相关概念视频
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antibiotic Selection
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
